| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.35 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |